JB
GTHX

Julian Baker’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Julian Baker’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-88,026
Closed -$970K – 121
2020
Q1 		$970K Sell
88,026
-39,210
-31% -$732K 0.01% 100
2019
Q4 		$3.36M Hold
127,236
– – 0.02% 80
2019
Q3 		$2.9M Hold
127,236
– – 0.02% 79
2019
Q2 		$3.9M Hold
127,236
– – 0.03% 67
2019
Q1 		$2.11M Hold
127,236
– – 0.01% 79
2018
Q4 		$2.44M Hold
127,236
– – 0.02% 69
2018
Q3 		$6.65M Sell
127,236
-42,256
-25% -$2.3M 0.04% 64
2018
Q2 		$7.37M Hold
169,492
– – 0.06% 63
2018
Q1 		$6.28M Buy
+169,492
New +$4.52M 0.05% 70

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Julian Baker's GTHX Position: Q2 2020 in Review

Julian Baker sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2020, closing a stake of 88,026 shares — an estimated $970K sold.

Julian Baker first reported a position in GTHX in Q1 2018 and held it in 9 quarters. The position peaked at $7.37M in Q2 2018. 100 funds tracked by Wall St. Rank hold GTHX as of Q2 2020.

  • Julian Baker reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Julian Baker sold 88,026 G1 Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $970K.
  • Julian Baker first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
  • Julian Baker's G1 Therapeutics, Inc. Common Stock position peaked at $7.37M in Q2 2018.
  • 100 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Baker Bros. Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.